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Abstract: In order to improve health care efficiency and effectiveness, treatments should 
provide disease improvement or resolution at a reasonable cost. The American Academy of 
Orthopedic Surgeons (AAOS) published a guideline for treatment of carpal tunnel syndrome 
(CTS) in 2009 based on review of the literature up to April 6, 2007. We have now reviewed the 
material published since then. Through reviewing evidence-based articles published during this 
period, this paper examines the current options and trends for treating CTS. We performed a 
systematic review of the randomized controlled trials, meta-analyses, systematic reviews, and 
practice guidelines to present the outcomes of current treatments for this disease. Twenty-five 
studies met our inclusion criteria. Thirteen randomized, controlled trials and 12 systematic 
reviews, including three Cochrane database systematic reviews, were retrieved. Our review 
revealed that most of the recent studies support the AAOS guideline. However, the recent litera-
ture demonstrates a trend towards recommending early surgery for CTS cases with or without 
median nerve denervation, although the AAOS guideline recommends early surgical treatment 
only for cases with denervation. The usefulness of splinting and steroids as initial treatments 
for improving patients’ symptoms are also supported by the recent literature, but these effects 
are temporary. The evidence level for ultrasound treatment is still low, and further studies are 
needed to determine the effectiveness of this treatment. Finally, our review revealed a paucity 
of articles comparing the costs of CTS diagnosis and treatment. With the recent focus on health 
care reform and rising costs, attention to the direct and indirect costs of health care is important 
for all conditions. Future well designed studies should include cost analyses to help determine 
the cost burden of CTS. 
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Introduction
Carpal tunnel syndrome (CTS), or median neuropathy, is a pathologic condition 
in which the median nerve is compressed at the wrist, leading to pain, paresthesia, 
  numbness, and weakness in the median nerve distribution of the hand (Figure 1). CTS 
is a common peripheral nerve entrapment syndrome that has received a lot of attention 
because of its association with work-related disability.1–3
Epidemiology
CTS is one of the most common hand disorders and entrapment neuropathies. 
The   highest incidence is among middle-aged and elderly women.4,5 The CTS inci-
dence rate in the US has been estimated at 1–3 per 1000 persons per year.6 The 
prevalence is approximately 50 cases per 1000 subjects in the general population.6,7 International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
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The large prevalence of CTS is an important issue in the 
workplace because it is directly related to waning productiv-
ity   resulting from work disability1–3 and is associated with 
high-cost treatment.8 According to a 2008 report from the 
Bureau of Labor   Statistics, CTS is associated with the second 
longest average time away from work (28 days) out of the 
major disabling diseases and illnesses in all private indus-
tries.9 Also,   according to the National Institutes of Health, 
the   average lifetime cost of CTS, including medical bills 
and loss time from work, is approximately $30,000 for each 
affected worker.10 As a result, choosing the proper treatment 
for CTS is crucial in improving patient quality of life and 
containing medical costs to a reasonable level.
Objectives
The aim of this article is to provide an evidence-based review 
of the most current treatment options and trends for CTS, 
including both conservative and surgical treatments.
In 2008, a systematic review and practice guideline 
entitled “Clinical Practice Guideline on the Treatment of 
Carpal Tunnel Syndrome” was undertaken by the American 
Academy of Orthopaedic Surgeons (AAOS), the summary of 
which was published in 2009.11 This guideline consists of nine 
specific recommendations and is useful for evidence-based 
clinical practice. The literature search undertaken in creating 
this guideline included articles from 1966 through April 6, 
2007. Almost three years have passed since this search and 
many new articles with high evidence-based analysis have 
been published. For clinicians to adhere to the most current 
evidence-based recommendations, it is important that we 
update the literature on treatment options and outcomes on a 
routine basis. In order to improve health care efficiency and 
effectiveness, treatments should provide disease improve-
ment or resolution at a reasonable cost. For common condi-
tions like CTS, preferentially allocating resources to a more 
effective treatment may have a large impact on reducing the 
overall national costs of treatment. Furthermore, the prac-
tice of patient-centered care by considering patients’ needs 
and activity levels are essential considerations in disease 
management.
Material and methods
Literature identification
The aim of our review is to provide optimal treatment 
recommendations based on the evidence available in the 
literature. We conducted a literature search using MedLine 
and the Cochrane Library to identify all citations of original 
research studies related to treatment in CTS. Details of the 
search strategy are given in Table 1.
Selection of studies
Based on title and abstract, two reviewers independently 
selected the trials to be included in this review. All articles 
selected by at least one of the reviewers were retrieved for 
examination. Articles fulfilling all the following inclusion 
criteria were included in the final review: (1) type of article 
(meta-analysis, practice guideline, randomized controlled trial 
or systematic review), (2) publication in English language, 
(3) published between April 7, 2007 and May 28, 2010, 
(4) study sample consisting of patients with clinically and/
or electrophysiologically confirmed CTS, and (5) evaluation 
of the efficacy of one or more treatment options. Reference 
lists of all relevant studies from the electronic search were 
manually searched to identify additional eligible studies.
Quality assessment
We considered the quality of the available evidence. Qual-
ity was determined using a “levels of evidence” approach, 
comprising five levels (Table 2). The higher the level of 
evidence, the greater the ability to draw causal inferences 
from the results of a study and, hence, the greater the quality 
of that study. This quality assessment is the same as that used 
Area supplied by the median nerve
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Figure 1 The carpal tunnel is a passageway through which nine flexor tendons and 
the median nerve pass in order to supply function, feeling, and movement to the 
thumb, index, middle and half of the ring finger.
Table 1 Search strategy
MeDLINe
  Carpal tunnel syndrome AND treatment
  Carpal tunnel syndrome AND surgery
  Carpal tunnel syndrome AND management
  Carpal tunnel release
CeNTRAL
  Carpal tunnel syndromeInternational Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
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for formulation of the AAOS Guideline on the Treatment of 
Carpal Tunnel Syndrome, available from http://www.aaos.
org/Research/Committee/Evidence/loetable1.pdf.
Data extraction and synthesis
The selected studies were gathered on the basis of kind of 
intervention, ie, surgical procedure, nonsurgical procedure, 
and postoperative treatment. The following data were 
extracted independently by two reviewers: characteristics 
of study design, population (size, age, gender, and duration 
of disease), intervention (details about surgical procedure), 
length of follow-up, outcome evaluation, and overall clini-
cal results. Conclusions of our search were compared with 
existing evidence or added as new knowledge. We discussed 
differences in recommendations based on outcomes and cost-
effectiveness based on the evidence in the CTS literature and 
the AAOS guidelines.
Results and discussion
Twenty-five studies met our inclusion criteria. Thirteen 
randomized controlled trials and 12 systematic reviews, 
including three Cochrane database systematic reviews, were 
retrieved.
Surgical versus nonsurgical treatment
Optimal treatment of CTS should be patient-oriented to 
provide patients with relief of symptoms, and as noninva-
sively, permanently, and inexpensively as possible. The 
treatment options for CTS are divided into two major groups, 
ie, nonsurgical and surgical. In 1993, the American Academy 
of Neurology’s official practice guidelines recommended 
treating CTS with noninvasive options first and considering 
surgery only if noninvasive treatment proved ineffective.12 
In recent years, however, initial surgical management has 
gained support, due to more accurate diagnostic techniques 
and the increased number of trained hand surgeons in the 
community.13 However, there is still controversy over 
whether surgical or nonsurgical treatment should be chosen 
as the initial treatment of CTS.
The AAOS guideline for the treatment of CTS14,15 rec-
ommends both nonsurgical and surgical treatments for early 
CTS without denervation of the median nerve, although they 
also recommend an initial course of nonoperative treatment. 
Surgery can then be considered if there is clinical evidence 
of median nerve denervation or if the patient would prefer 
surgery over conservative management.14 In fact, the recent 
literature demonstrates a trend towards recommending early 
surgery with or without median nerve denervation.13 In 2009, 
a study of 116 patients with CTS compared the treatment 
outcomes between an experimental group of 57 patients 
who received surgical management and a control group of 
59 patients who received a nonsurgical treatment regimen 
of hand therapy and ultrasound. The results showed that the 
surgical group achieved modestly better outcomes in terms 
of hand function and symptoms at both three months and 
one year when compared with the control group (Level I).13 
Another meta-analysis concluded that surgical treatment 
relieves symptoms better than splinting, but the evidence 
for surgical treatment being superior to steroid injections is 
unclear (Level I).16 Therefore, more research is needed to 
determine the best treatment for patients with mild to moder-
ate symptoms, as well as to identify which patients should 
forego conservative management and undergo surgery as 
the initial treatment.
Moreover, several economic analyses suggest that surgery 
should be considered as the initial form of treatment when the 
diagnosis of CTS is confirmed by nerve conduction studies, 
because the surgical treatment option has the most favorable 
cost-utility ratio.17,18
Nonsurgical treatments
Only three conservative treatments are supported by a sub-
stantial body of experimental evidence: splinting, steroids, 
and ultrasound.19 The AAOS recommends that when initial 
conservative treatment fails to resolve a patient’s symptoms 
within 2–7 weeks, physicians should move on to another 
nonoperative treatment or surgery.
Table 2 Levels of evidence for therapeutic studies investigating 
the results of treatment
Level I
    High quality, randomized trial with statistically significant difference or 
no statistically significant difference but narrow confidence intervals
    Systematic review of Level I randomized controlled trials (and study 
results were homogenous)
Level II
    Lesser quality randomized controlled trial (, 80% follow-up, no 
blinding, or improper randomization)
  Prospective comparative study
    Systematic review of Level II or Level I studies with inconsistent 
results
Level III
  Case-control study
  Retrospective comparative study
  Systematic review of Level III studies
Level Iv
  Case series
Level v
  expert opinionInternational Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
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Splinting
For patients with mild CTS symptoms, the simplest treatment 
is a night splint. Splinting has the advantage of being 
inexpensive and is associated with a minimal complication 
rate. The immobilization may decrease the pressure around 
the soft tissue in the carpal tunnel, which enhances blood 
circulation and relieves pressure on the median nerve. For 
this reason, splinting provides many patients with relief 
from the numbness and tingling sensation experienced at 
night or during extended periods of rest. For some patients, 
wearing a splint may also be necessary during the day. The 
AAOS recommends that splinting be considered before 
surgery when treating CTS. Recent evidence-based stud-
ies (Level II)19,20 also support this suggestion. Specifically, 
research suggests that a splint that maintains the wrist in the 
neutral position may be more effective than a wrist cock-up 
splint (Level II).21 We can conclude that splinting for CTS 
is useful for relief of some symptoms in the early stages of 
CTS, and has the benefits of being cost-effective and without 
serious adverse effects. It should be considered as an initial 
treatment option before considering surgery, especially in 
mild or moderate cases.
Steroids
The AAOS recommends local steroid injection when treat-
ing CTS before surgery is considered, and oral steroids as a 
secondary option. Their report also concluded that steroids 
are more effective than nonsteroidal anti-inflammatory 
drugs and diuretics, but also have the potential for more 
serious side effects. This conclusion is supported by a recent 
study by Marshall et al who concluded that local steroid 
injections are more effective than oral steroids for up to 
three months (Level II).22 On the other hand, another recent 
study indicated that local steroid injection and nonsteroidal 
anti-inflammatory drugs with concomitant use of wrist 
splints might offer patients with CTS variable and effective 
treatment options for the management of functional scores 
and nerve conduction parameters (Level II).23 Moreover, 
a further study revealed that corticosteroid iontophoresis 
was not effective in the treatment of mild to moderate CTS 
(Level II).
As a result, steroid treatment for CTS, particularly local 
injection, is effective for temporary relief of symptoms 
in many patients. However, the efficacy and duration of 
symptom relief with the steroid injections are still unknown. 
Further investigation is needed to determine the long-term 
outcomes of local steroid injection and how many times and 
how frequently the steroid injections should be repeated.
Ultrasound
Ultrasound treatment consists of directing high-frequency 
sound waves at the inflamed area. The sound waves 
are   converted into heat in the deep tissues of the hand, and 
are presumed to open the blood vessels, allowing oxygen to 
be delivered to the injured tissue. As a result, it is suggested 
that ultrasound therapy may accelerate the healing process 
in   damaged tissues.24 It is often prescribed along with nerve 
and tendon exercises. The AAOS guideline recommends 
ultrasound treatment of CTS. However, this   recommendation 
was based on the results of only two studies, hence the low 
evidence level of this recommendation.24,25 To increase the 
evidence level of ultrasound treatment for CTS, we need 
  further studies comparing an ultrasound group against a 
placebo group. There was no updated information in this 
regard.
Surgical treatments
Carpal tunnel release (CTR) is the most common hand 
and wrist surgery performed in the US, with an estimated 
400,000 operations performed per year.26 CTR as an 
effective treatment for CTS is supported by high quality 
  evidence.14 There are several variations of CTR surgery. 
The two major types are open carpal tunnel release (OCTR) 
and endoscopic carpal tunnel release (ECTR). OCTR can be 
further classified into full-open and mini-open with a one 
inch incision. Regardless of selection of these treatment 
options, the most important thing is complete division of 
the flexor retinaculum.14
Open carpal tunnel release
Traditionally, OCTR was done through a relatively large 
4–5 cm longitudinal incision extending from Kaplan’s 
cardinal line distally to beyond the wrist crease proxi-
mally (Figure 2). Over time, the size of this incision has 
gradually decreased, and most hand surgeons today perform 
primary OCTR through a 2–4 cm incision, which ends 
approximately 2 cm distal to the wrist crease. OCTR has 
been shown to be an effective and relatively safe procedure, 
and is   established as the standard surgical treatment for 
CTS.27,28 It has produced uniformly excellent results, with 
high patient satisfaction and a low complication rate.29,30 
The outcome of this procedure can be complicated by scar 
tenderness, grip and pinch weakness, and pillar pain, which 
are all related to the incision.
There are two recent publications concerning OCTR. The 
Cochrane database of systematic reviews concluded that there 
was no strong evidence supporting the need for replacement International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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incision site
median nerve
thenar motor branch
Figure 2 Open carpal tunnel release.
portal sites for endoscope
endoscope
Figure 3 endoscopic carpal tunnel release.
of standard OCTR by alternative   surgical   procedures for the 
treatment of CTR (Level I).31 In contrast, the other study 
  compared conventional OCTR with the double-incision 
  technique and showed that the limited open technique using 
the double incision was   advantageous   compared with the stan-
dard technique in tackling   scar-related morbidities in terms of 
decreasing pillar pain and scar sensitivity (Level II).32
endoscopic carpal tunnel release
ECTR refers to a method of performing CTR using an 
endoscope or arthroscopic device33 (Figure 3). This entails 
a less invasive procedure than standard OCTR. ECTR 
was invented to address the potential complications of 
OCTR by using smaller incisions placed away from the 
middle of the palm.34,35 It is assumed that preservation of 
the   superficial fascia and adipose tissue over the flexor 
  retinaculum allows faster recovery of grip strength, less scar 
tenderness and pillar pain, and earlier return to work.35,36 
According to the AAOS guideline,14 endoscopic release 
offers better outcomes than OTCR at 12 weeks after sur-
gery in terms of pain relief, time until return to work, and 
wound-related complications. In recent studies comparing 
OCTR and   two-portal ECTR, Atroshi et al37 reported that 
the outcomes were equivalent, other than ECTR offering a 
shorter recovery period.   However, critics of ECTR report 
higher complication rates38–40 due to the technical difficulty 
of the procedure, as well as greater cost when compared with 
OCTR.35,41 However, experienced surgeons can successfully 
complete the operation without too many complications.42 
Therefore, the decision to perform ECTR is influenced by the 
surgeon’s experience and patient factors, including occupa-
tion, socioeconomic status, and preference. This evidence is 
also supported by the recent Cochrane database systematic 
review. They concluded that the decision to perform ECTR 
instead of OCTR seems to be guided by the surgeon’s and 
patient’s preferences (Level I).31
Mini-open carpal tunnel release43,44
In recent years, many surgeons have adopted the “mini” 
OCTR, also called the short-incision procedure. The idea 
behind the “mini” procedure is to combine the simplicity 
and safety of OCTR with the reduced tissue trauma and International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
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postoperative morbidity of ECTR by using a short-incision, 
open technique. The incision begins just distal to the 
distal wrist crease and extends no further than Kaplan’s 
cardinal line, which extends along the distal border of 
the outstretched thumb obliquely toward the pisiform 
(Figure 4).
According to the AAOS guideline, when minimal   incision 
release was compared with open release in Level I studies, 
minimal incision release offered superior outcomes in terms 
of symptom relief, functional status, and scar tenderness. 
When compared with endoscopic release, minimal incision 
was favored when pain at two or four weeks was the outcome 
measure.14,42 On the other hand, Cellocco et al45 prospectively 
compared the safety and effectiveness of mini-incision 
(less than 2 cm), and a limited open technique (3–4 cm) 
for CTR in 185 consecutive patients, with a   five-year 
minimum   follow-up. Patient status was evaluated with a 
modified   version of the Boston Carpal Tunnel questionnaire, 
  administered preoperatively and at 19, 30, and 60 months 
postoperatively. Mini-incision CTR had superior outcomes 
over the standard technique in terms of recovery time, pillar 
pain, and   recurrence rate (Level II).
Conclusion
In order to improve health care efficiency and effectiveness, 
treatments should provide disease improvement or resolution 
at reasonable cost. Furthermore, we should always think about 
patient-centered care in determining the best treatment for 
each patient’s condition. When considering the treatment 
options for CTS, only four treatments are supported by some 
evidence: splinting, steroids, ultrasound, and surgery. Splint-
ing and steroids are useful as initial treatment for improving 
symptoms, but their effects are temporary. The evidence level 
for ultrasound treatment is poor and further investigations are 
needed. Moreover, early treatment using mini-OCTR appears 
to be the preferred treatment approach.
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